Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of glucose for energy production or storage.

Initiation of Autoimmunity

The autoimmune cascade begins when antigen-presenting cells activate T helper 1 (Th1) lymphocytes against β-cell antigens. Activated Th1 cells produce pro-inflammatory cytokines, including interleukin-2 (IL-2) and interferon-gamma (IFN-γ). IFN-γ plays a central role in amplifying the immune response by promoting macrophage activation and enhancing antigen presentation. These cytokines contribute to the development of insulitis, an inflammatory infiltration of the islets characterized by T cells, macrophages, and other immune effectors that progressively damage β-cells.

Progressive β-Cell Destruction

As inflammatory signaling persists, the structural and functional integrity of β-cells is increasingly compromised. Chronic exposure to cytotoxic mediators leads to apoptosis and eventual depletion of β-cell mass. Genetic predisposition, including susceptibility alleles within the HLA-DRB103 and HLA-DRB104 loci, influences the likelihood of developing this autoimmune response, while environmental triggers—such as viral infections—may precipitate or accelerate β-cell injury.

Consequences of Insulin Deficiency

With diminishing β-cell function, insulin production declines to levels insufficient for normal glucose regulation. Because insulin is required for glucose uptake into muscle and adipose tissue, its absence causes glucose to accumulate in the bloodstream. The resulting hyperglycemia marks the clinical onset of type 1 diabetes and underlies the acute metabolic disturbances and long-term complications associated with the disease.